(Q36085594)

12 August 2017

1 reference

title

Reproducibility and variability in the action of injected insulin (English)

1 reference

12 August 2017

1 reference

Gin H

1

1 reference

PubMed ID

15803107

12 August 2017

Hanaire-Broutin H

series ordinal

2

1 reference

PubMed ID

15803107

12 August 2017

language of work or name

1 reference

1 February 2005

1 reference

12 August 2017

Diabetes and Metabolism

1 reference

12 August 2017

31

1 reference

12 August 2017

1

1 reference

12 August 2017

7-13

1 reference

Characteristics of glycemic stability

12 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970160-X

7 January 2021

Variation in absorption of NPH insulin due to intramuscular injection

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970160-X

7 January 2021

Factors influencing the absorption, serum insulin concentration, and blood glucose responses after injections of regular insulin and various insulin mixtures.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970160-X

7 January 2021

The use of human ultralente is limited by great intraindividual variability in overnight plasma insulin profiles

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970160-X

7 January 2021

Monomeric insulins and their experimental and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970160-X

7 January 2021

Variability of the metabolic effect of soluble insulin and the rapid-acting insulin analog insulin aspart

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970160-X

7 January 2021

Monomeric insulins obtained by protein engineering and their medical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970160-X

7 January 2021

Rapid and long-acting analogues as an approach to improve insulin therapy: an evidence-based medicine assessment

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970160-X

7 January 2021

Limitations to subcutaneous insulin administration in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970160-X

7 January 2021

Pharmacokinetics and pharmacodynamics of insulin aspart, a rapid-acting analog of human insulin, in healthy Japanese volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970160-X

7 January 2021

Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970160-X

7 January 2021

Comparison of the soluble basal insulin analog insulin detemir with NPH insulin: a randomized open crossover trial in type 1 diabetic subjects on basal-bolus therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970160-X

7 January 2021

Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970160-X

7 January 2021

Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970160-X

7 January 2021

Establishment of time-action profiles for regular and NPH insulin using pharmacodynamic modeling

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970160-X

7 January 2021

Dose-dependent Subcutaneous Absorption of Porcine, Bovine and Human NPH Insulins

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970160-X

7 January 2021

Variability of insulin absorption and insulin action

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970160-X

7 January 2021

Intramuscular versus subcutaneous injection of unmodified insulin: consequences for blood glucose control in patients with type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970160-X

7 January 2021

Alterations in insulin absorption and in blood glucose control associated with varying insulin injection sites in diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970160-X

7 January 2021

Absorption of injected insulin. A clinical-pharmacological study

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970160-X

7 January 2021

Pharmacokinetics of 125I-labeled insulin glargine (HOE 901) in healthy men: comparison with NPH insulin and the influence of different subcutaneous injection sites.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970160-X

7 January 2021

Insulin loss at the injection site in children with type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970160-X

7 January 2021

Inadequate suspension of neutral protamine Hagendorn (NPH) insulin in pens

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970160-X

7 January 2021

Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970160-X

7 January 2021

Effect of raising injection-site skin temperature on isophane (NPH) insulin crystal dissociation

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970160-X

7 January 2021

Impact of diabetic nephropathy on pharmacodynamic and Pharmacokinetic properties of insulin in type 1 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970160-X

7 January 2021

Is HbA1c Affected by Glycemic Instability?

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970160-X

7 January 2021

10.1016/S1262-3636(07)70160-X

Identifiers

DOI

1 reference

12 August 2017

1 reference

PubMed ID

15803107